NCT03234478View on ClinicalTrials.gov

Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
ParkinsonParkinson DiseaseGenetic PredispositionGBA Gene MutationCognitive Decline
Interventions
OTHER

cognitive assessments

Cognitive assessments will be performed at baseline, 1 year, and 2 years, depending on subject cohort placement

Trial Locations (1)

08901

Rutgers-Robert Wood Johnson Medical School, New Brunswick

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Rutgers, The State University of New Jersey

OTHER

NCT03234478 - Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers | Biotech Hunter | Biotech Hunter